Volume 32 Issue 1, July 2003

Mini Review

Hematopoietic stem cell gene therapy: progress toward therapeutic targets

J L Vollweiler
S P Zielske
S L Gerson
Mini Review 23 Jun 2003
Advertisement

Top of page ⤴

Original Article

Safety and outcome after fludarabine–thiotepa–TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies

K van Besien
S Devine
J Sosman
Original Article 23 Jun 2003
Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers

M van Pel
D W J G van Breugel
C J P Boog
Original Article 23 Jun 2003
Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback

S Chakrabarti
J Brown
D I Marks
Original Article 23 Jun 2003
Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF

C Kaplinsky
L Trakhtenbrot
S Izraeli
Original Article 23 Jun 2003
Stem cell transplantation for myelofibrosis: a report from two Canadian centers

A Daly
K Song
T Kiss
Original Article 23 Jun 2003
Oestrogen receptor α gene polymorphism associates with occurrence of graft-versus-host disease and reduced survival in HLA-matched sib-allo BMT

P G Middleton
J Norden
A M Dickinson
Original Article 23 Jun 2003
Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model

G Hartung
M Zeis
L Uharek
Original Article 23 Jun 2003
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

S Galimberti
F Guerrini
M Petrini
Original Article 23 Jun 2003
A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors

S L Petersen
L P Ryder
L L Vindeløv
Original Article 23 Jun 2003
Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience¹

I A Hassan
R Chopra
K J Mutton
Original Article 23 Jun 2003
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients

C C Barker
J D Butzner
R S Sauve
Original Article 23 Jun 2003
Autoimmune thrombocytopenic purpura after autologous stem cell transplantation

O Hequet
G Salles
B Coiffier
Original Article 23 Jun 2003
High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment

E Juvonen
S M Aalto
K Hedman
Original Article 23 Jun 2003

Top of page ⤴

Case Report

Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation

M Inoue
T Nakano
K Kawa
Case Report 23 Jun 2003
Complete resolution of severe chronic active Epstein–Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting

F Yoshiba
M Hagihara
T Hotta
Case Report 23 Jun 2003
Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation

T-Y Chen
J-S Chen
C-J Tsao
Case Report 23 Jun 2003
Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation

H Orlent
C Crawley
J Apperley
Case Report 23 Jun 2003

Top of page ⤴

Correspondence

Utility of antigenemia test for cytomegalovirus detection in hematopoietic transplant recipients: report of experiences from Medellín, Colombia

M Sarmiento-Maldonado
M Eugenia Castaño-Orozco
F Cuellar-Ambrosi
Correspondence 23 Jun 2003

Top of page ⤴

Supplement

Stem Cells for Tolerance and Tissue Regeneration

This supplement includes the proceedings from the Snowbird 2002 meeting, which provided an avenue for international experts from around the globe to discuss advancements that transcend traditional departmental, divisional, clinical, and research barriers.

Supplement 21 Aug 2003

Top of page ⤴

Volume 32 Issue 1, July 2003

Mini Review

Hematopoietic stem cell gene therapy: progress toward therapeutic targets

Original Article

Safety and outcome after fludarabine–thiotepa–TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies

Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers

Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback

Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF

Stem cell transplantation for myelofibrosis: a report from two Canadian centers

Oestrogen receptor α gene polymorphism associates with occurrence of graft-versus-host disease and reduced survival in HLA-matched sib-allo BMT

Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model

Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors

Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience¹

Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients

Autoimmune thrombocytopenic purpura after autologous stem cell transplantation

High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment

Case Report

Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation

Complete resolution of severe chronic active Epstein–Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting

Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation

Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation

Correspondence

Utility of antigenemia test for cytomegalovirus detection in hematopoietic transplant recipients: report of experiences from Medellín, Colombia

Supplement

Stem Cells for Tolerance and Tissue Regeneration

Search

Quick links